Innovation made in India
As the world closes its doors and builds walls, India can chart its own course by leading the next wave of affordable, accessible…
Author
India is potentially on track to becoming a $300 billion bioeconomy
To understand the landscape better, how big is biopharma in India? Where are we headed, and what role does Thermo Fisher play in…
Supply chain leadership: Stepping into the spotlight
As pharma supply chains rise in strategic importance, its leaders must sharpen their business acumen and competencies to keep pace…
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a…
Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease…
On the occasion of World Liver Day, Jayashree Aiyar, Chief Scientific Officer, Syngene International shared her insights into a…
Integrated research campuses: Future of Hyderabad’s life sciences industry
Vishal Goel, MD, RX Propellant outlines how transitioning from isolated industrial clusters to integrated research campuses can…
Emcure Pharmaceuticals launches campaign addressing male anaemia
MS Dhoni leads awareness initiative to tackle rising prevalence of anaemia among Indian men
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead – DevOps and Cloud Engineering Practice, Altimetrik explains how the industry can obtain…
UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment
With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand…